Immuneering Corporation
IMRX • NASDAQ • Stock Fundamentals
Immuneering Corporation is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Benjamin J. Zeskind, with a market cap of $348.7M.
Market Cap$348.7M
Employees65.0
CEOBenjamin J. Zeskind
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 15, 2026 · 12 days agoQ1 2026
View reportNext EarningsAug 12, 2026 · in 2 monthsQ2 2026
Financials
Based on Q1 2026 filing
Immuneering Corporation FAQ
Common questions about Immuneering Corporation
Immuneering Corporation (IMRX) has a market capitalization of $348.7M and trades on NASDAQ.
Immuneering Corporation has approximately 65 employees.